©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 106685
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.106685
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.106685
Table 2 Clinical characteristics of the modeling and validation sets, n (%)
| Index | Modeling group (n = 253) | Validation group (n = 50) | P value |
| Gender | 0.416 | ||
| Male | 167 (66.0) | 30 (60.0) | |
| Female | 86 (34.0) | 20 (40.0) | |
| Age (years) | 61 ± 9 | 62 ± 7 | 0.686 |
| BMI (kg/m2) | 23.1 ± 2.7 | 22.4 ± 3.3 | 0.312 |
| Alcohol consumption | 0.246 | ||
| Yes | 48 (19.0) | 13 (26.0) | |
| No | 205 (81.0) | 37 (74.0) | |
| Smoking | 0.846 | ||
| Yes | 110 (43.5) | 21 (42.0) | |
| No | 143 (56.5) | 29 (58.0) | |
| Diabetes | 0.983 | ||
| Yes | 56 (22.1) | 11 (22.0) | |
| No | 197 (77.9) | 39 (78.0) | |
| Main pancreatic duct diameter (mm) | 3.8 ± 2.1 | 3.7 ± 2.2 | 0.606 |
| Cutting edge pancreatic thickness (mm) | 15.3 ± 3.5 | 14.7 ± 3.1 | 0.220 |
| Main pancreatic duct index | 0.3 ± 0.2 | 0.3 ± 0.2 | 0.885 |
| Portal vein invasion | 0.901 | ||
| Yes | 16 (6.3) | 4 (8.0) | |
| No | 237 (93.7) | 46 (92.0) | |
| Intra-abdominal fat thickness (mm) | 71.1 ± 27.2 | 68.3 ± 25.3 | 0.389 |
| Pancreatic CT value (HU) | 38.6 ± 8.3 | 38.1 ± 8.8 | 0.693 |
| Preoperative biliary drainage | 0.707 | ||
| Yes | 30 (11.9) | 5 (10.0) | |
| No | 223 (88.1) | 45 (90.0) | |
| Preoperative laboratory examination | |||
| White blood cells | 6.1 ± 1.7 | 5.9 ± 1.6 | 0.397 |
| Platelets | 232.5 ± 68.5 | 240.3 ± 62.8 | 0.316 |
| Albumin (g/L) | 39.3 ± 4.1 | 38.7 ± 3.8 | 0.662 |
| Total bilirubin (μmol/L) | 121.3 (34.1-231.4) | 130.5 (39.2-190.0) | 0.747 |
| Serum amylase (IU/L) | 25.0 (16.0-42.0) | 26.0 (19.5-39.3) | 0.737 |
| CA19-9 (U/mL) | 81.9 (34.2-273.1) | 94.0 (28.5-357.5) | 0.626 |
| Pancreatic intestinal anastomosis method | 0.814 | ||
| Pancreatic duct jejunal mucosa vs mucosa | 47 (18.6) | 10 (20.0) | |
| Pancreatic intestinal end to side insertion | 206 (81.4) | 40 (80.0) | |
| Pancreatic cancer | 0.684 | ||
| Yes | 59 (23.3) | 13 (26.0) | |
| No | 194 (76.7) | 37 (74.0) | |
| Postoperative pancreatic dysfunction | |||
| ISGPF | 0.517 | ||
| Yes | 124 (49.0) | 22 (44.0) | |
| No | 129 (51.0) | 28 (56.0) | |
| ISGPS | 0.987 | ||
| Yes | 61 (24.1) | 12 (24.0) | |
| No | 192 (75.9) | 38 (76.0) | |
| Surgical related deaths | 0.658 | ||
| Yes | 8 (3.2) | 1 (2.0) | |
| No | 245 (96.8) | 49 (98.0) |
- Citation: Yao L, Zhu K, Yuan J, Luo ZX, Huang WG. Retrospective investigation of risk factors for pancreatic fistula development after pancreaticoduodenectomy. World J Gastrointest Surg 2025; 17(10): 106685
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/106685.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.106685